Regulus amends follow-on

Regulus Therapeutics Inc. (NASDAQ:RGLS), San Diego, Calif. Business: Infectious, Cancer, Cardiovascular Date announced: 7/8/13 Type: Follow-on To be raised: Up to $58 million Shares: 4.5 million Price...